The US Food and Drug Administration (FDA) has launched a new programme aimed at accelerating the development of potential treatments for Covid-19 infection.

Under the Coronavirus Treatment Acceleration Program (CTAP), FDA is working to quickly bring therapies to patients.

Furthermore, the agency is supporting research to validate the safety and effectiveness of these Covid-19 treatments.

Read the full article here